Winnipeg-based Medicure is focused on advancing and marketing pharmaceuticals and healthcare products for the US market. Aggrastat and Zypitamag are commercialised in the US cardiovascular segments, and Medicure also operates a US pharmacy subsidiary, Marley Drug. It is also advancing MC-1 in a Phase III study for a rare paediatric seizure indication.
Albert D. Friesen
CEO
James Kinley
CFO
thematic
Consumer
thematic
Energy & Resources